Trials / Completed
CompletedNCT01163630
Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg
A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination Capsule of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to investigate the effects of food, in comparison to fasting conditions, on the extent and rate of absorption of acetylsalicylic acid (ASA) and esomeprazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | esomeprazole/ASA Fixed Dose Combination (FDC) | esomeprazole 20 mg/ASA 81 mg oral capsule |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2010-07-16
- Last updated
- 2010-12-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01163630. Inclusion in this directory is not an endorsement.